Anteilseigner
Venrock Associates (7,52 %) The Vanguard Group, Inc. (4,13 %) Deep Track Capital LP (4,11 %) Vestal Point Capital LP (3,98 %) Acadian Asset Management LLC (3,91 %) Parsons Capital Management, Inc. (3,23 %) Opaleye Management, Inc. (2,52 %) Palo Alto Investors LP (2,43 %) Vivo Capital LLC (2,36 %) Franklin Advisers, Inc. (2,09 %) BlackRock Fund Advisors (1,88 %) Millennium Management LLC (1,13 %) Two Sigma Advisers LP (1,08 %) Geode Capital Management LLC (0,85 %) Two Sigma Investments LP (0,75 %) DWS Investments (UK) Ltd. (0,75 %) Marshall Wace LLP (0,69 %) BofA Securities, Inc. (0,65 %)
Kontakt
Relmada Therapeutics Inc.